Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer

INTRODUCTION: The addition of stereotactic ablative radiotherapy (SABR) to standard of care for patients with oligometastatic prostate cancer has the potential of improving survival and delaying further metastases. The primary aim of this analysis is to report survival outcomes and pattern of recurr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercier, Carole, Claessens, Marc, De Troyer, Bart, Debacker, Tibaut, Fransis, Karen, Vandeursen, Hendrik, Ost, Piet, Dirix, Piet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046565/
https://www.ncbi.nlm.nih.gov/pubmed/35494057
http://dx.doi.org/10.3389/fonc.2022.863609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046565/
https://www.ncbi.nlm.nih.gov/pubmed/35494057
http://dx.doi.org/10.3389/fonc.2022.863609

Ejemplares similares